These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3068399)

  • 1. [Use of urokinase in acute myocardial infarction].
    Bokarev IN; Makolkin VI; Butorov VN; Terekhov VN; Kuznetsov VA
    Kardiologiia; 1988 Nov; 28(11):36-40. PubMed ID: 3068399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction].
    Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y
    Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intracoronary and intravenous urokinase in acute myocardial infarction.
    Cernigliaro C; Sansa M; Campi A; Bongo AS; Carfora A; Rossi P
    G Ital Cardiol; 1984 Nov; 14(11):927-30. PubMed ID: 6526208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic effects of pro-urokinase combined with low-dose urokinase compared to high-dose urokinase in patients with acute myocardial infarction.
    Pindur G; Koehler M; Sen S; Hermes R; Miyashita C; Wenzel E; Schieffer H
    Thromb Res; 1992 Jul; 67(2):191-200. PubMed ID: 1279835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of urokinase for intracoronary thrombolysis in patients with acute myocardial infarction.
    Ohyagi A; Hirose K; Watanabe Y; Nakai T; Tsujimoto S; Doyama K; Suzuki Y; Okazaki S; Hirai M
    Clin Cardiol; 1987 Aug; 10(8):453-6. PubMed ID: 3621694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic therapy urokinase for myocardial infarction.
    Nakano M
    Angiology; 1983 Oct; 34(10):654-73. PubMed ID: 6625222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An allergic reaction due to i.v. urokinase administration].
    Mastrogiuseppe G; Tullio D
    Minerva Cardioangiol; 1994 Oct; 42(10):507-8. PubMed ID: 7816241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
    Bai XJ; Chen CX; He YL
    Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of renokinase on the space velocity of coronary vein flow during systemic administration to patients with acute myocardial infarct].
    Terekhov VN; Bogatyrev IV; Makolkin VI; Syrkin AL; Bokarev IN
    Kardiologiia; 1988 May; 28(5):29-32. PubMed ID: 3411856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of systemic thrombolytic therapy on necrotic focus formation in myocardial infarct patients].
    Golikov AP; Zvereva TV; Polumiskov VIu; Avilova OA
    Kardiologiia; 1984 Sep; 24(9):47-50. PubMed ID: 6521247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic thrombolytic therapy of myocardial infarction].
    Golikov AP; Zvereva TV; Kuzina NG
    Kardiologiia; 1985 Oct; 25(10):34-40. PubMed ID: 3910908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of a systemic fibrinolytic treatment of acute myocardial infarction. The effect of a moderate dose infusion of urokinase].
    Takayama M
    Nihon Ika Daigaku Zasshi; 1991 Aug; 58(4):8-20. PubMed ID: 1918275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous urokinase in acute myocardial infarction.
    Mathey DG; Schofer J; Sheehan FH; Becher H; Tilsner V; Dodge HT
    Am J Cardiol; 1985 Apr; 55(8):878-82. PubMed ID: 3984876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy on the homefront. Intravenous urokinase in community hospitals.
    Wall TC; Strickland J; Masoud J; Tse A; Pasi D; Zawodniak M; Anderson J; Hoekstra J; Mantell S; Sigmon K
    N C Med J; 1989 Jul; 50(7):363-6. PubMed ID: 2755512
    [No Abstract]   [Full Text] [Related]  

  • 19. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pro-urokinase for infarct therapy].
    Spiecker M; Meyer J
    Herz; 1994 Dec; 19(6):326-35. PubMed ID: 7843689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.